Ilex Medical Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Ilex Medical.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth	17.6%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Are Robust Financials Driving The Recent Rally In Ilex Medical Ltd's (TLV:ILX) Stock?

Feb 16

What Type Of Shareholders Make Up Ilex Medical Ltd's (TLV:ILX) Share Registry?

Feb 04

Here's Why I Think Ilex Medical (TLV:ILX) Is An Interesting Stock

Jan 24

Shareholders of Ilex Medical (TLV:ILX) Must Be Delighted With Their 333% Total Return

Jan 11

Ilex Medical (TLV:ILX) Has A Rock Solid Balance Sheet

Dec 23

What Can We Make Of Ilex Medical's (TLV:ILX) CEO Compensation?

Nov 28

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ilex Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TASE:ILX - Analysts future estimates and past financials data (ILS Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2024	961	56	86	131	N/A
12/31/2023	931	51	28	80	N/A
9/30/2023	880	67	-24	32	N/A
6/30/2023	858	77	48	96	N/A
3/31/2023	829	66	33	74	N/A
12/31/2022	873	102	41	70	N/A
9/30/2022	895	107	152	178	N/A
6/30/2022	1,005	172	229	256	N/A
3/31/2022	1,031	203	192	218	N/A
12/31/2021	1,061	197	228	271	N/A
9/30/2021	1,077	185	171	223	N/A
6/30/2021	1,065	150	103	165	N/A
3/31/2021	1,059	146	147	208	N/A
12/31/2020	946	121	136	182	N/A
9/30/2020	843	101	80	116	N/A
6/30/2020	704	71	106	139	N/A
3/31/2020	659	61	28	63	N/A
12/31/2019	634	60	54	85	N/A
9/30/2019	645	64	55	83	N/A
6/30/2019	632	57	39	62	N/A
3/31/2019	613	53	55	79	N/A
12/31/2018	601	47	34	59	N/A
9/30/2018	561	39	57	78	N/A
6/30/2018	558	36	40	62	N/A
3/31/2018	551	34	50	70	N/A
12/31/2017	554	37	N/A	76	N/A
9/30/2017	545	36	N/A	41	N/A
6/30/2017	535	36	N/A	57	N/A
3/31/2017	536	32	N/A	18	N/A
12/31/2016	519	28	N/A	13	N/A
9/30/2016	527	27	N/A	32	N/A
6/30/2016	512	25	N/A	10	N/A
3/31/2016	497	27	N/A	39	N/A
12/31/2015	497	31	N/A	45	N/A
9/30/2015	478	23	N/A	55	N/A
6/30/2015	464	32	N/A	85	N/A
3/31/2015	452	30	N/A	86	N/A
12/31/2014	433	22	N/A	80	N/A
9/30/2014	443	-12	N/A	67	N/A
6/30/2014	448	-24	N/A	48	N/A
3/31/2014	453	-26	N/A	40	N/A
12/31/2013	461	-22	N/A	22	N/A
9/30/2013	450	-14	N/A	29	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ILX's forecast earnings growth is above the savings rate (2.1%).

Earnings vs Market: Insufficient data to determine if ILX's earnings are forecast to grow faster than the IL market

High Growth Earnings: Insufficient data to determine if ILX's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if ILX's revenue is forecast to grow faster than the IL market.

High Growth Revenue: Insufficient data to determine if ILX's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ILX's Return on Equity is forecast to be high in 3 years time

Ilex Medical Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Insufficient new directors

Dividend of ₪1.36 announced

Full year 2023 earnings released

Ilex Medical Ltd (TLV:ILX) Investors Are Less Pessimistic Than Expected

Third quarter 2023 earnings released: EPS: ₪0.79 (vs ₪1.70 in 3Q 2022)

Ilex Medical Ltd, Annual General Meeting, Jan 04, 2024

Second quarter 2023 earnings released: EPS: ₪0.95 (vs ₪0.005 in 2Q 2022)

First quarter 2023 earnings released: EPS: ₪0.80 (vs ₪3.96 in 1Q 2022)

Full year 2022 earnings released: EPS: ₪9.05 (vs ₪17.51 in FY 2021)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Ilex Medical (TLV:ILX) Could Easily Take On More Debt

Investor sentiment improved over the past week

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

The Trend Of High Returns At Ilex Medical (TLV:ILX) Has Us Very Interested

Second quarter 2021 earnings released: EPS ₪2.76 (vs ₪2.63 in 2Q 2020)

Ilex Medical Ltd(TASE:ILX) dropped from TA-125 Index

Returns On Capital Are A Standout For Ilex Medical (TLV:ILX)

Here's Why We Think Ilex Medical (TLV:ILX) Is Well Worth Watching

Ilex Medical (TLV:ILX) Could Easily Take On More Debt

Is It Smart To Buy Ilex Medical Ltd (TLV:ILX) Before It Goes Ex-Dividend?

Full year 2020 earnings released: EPS ₪11.30 (vs ₪6.01 in FY 2019)

Ilex Medical Ltd to Report Q4, 2020 Results on Mar 15, 2021

Ilex Medical (TLV:ILX): Are Investors Overlooking Returns On Capital?

Are Robust Financials Driving The Recent Rally In Ilex Medical Ltd's (TLV:ILX) Stock?

What Type Of Shareholders Make Up Ilex Medical Ltd's (TLV:ILX) Share Registry?

Here's Why I Think Ilex Medical (TLV:ILX) Is An Interesting Stock

Shareholders of Ilex Medical (TLV:ILX) Must Be Delighted With Their 333% Total Return

Ilex Medical (TLV:ILX) Has A Rock Solid Balance Sheet

New 90-day low: ₪106

What Can We Make Of Ilex Medical's (TLV:ILX) CEO Compensation?

New 90-day low: ₪113

Market pulls back on stock over the past week

New 90-day high: ₪143

New 90-day high - ₪138

New 90-day high - ₪125

Earnings released

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies